Literature DB >> 3540912

Endogenous opiates: 1985.

G A Olson, R D Olson, A J Kastin.   

Abstract

This paper is the eighth installment of our annual review of research involving the endogenous opiate peptides. It is restricted to the non-analgesic and behavioral studies of the opiate peptides published in 1985. The specific topics this year include stress, tolerance and dependence, eating, drinking and alcohol consumption, gastrointestinal and renal activity, mental illness, learning and memory, cardiovascular responses, respiration and thermoregulation, seizures and neurological disorders, activity, and some other selected topics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540912     DOI: 10.1016/0196-9781(86)90113-0

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Immunohistochemical evidence for the presence of peptides derived from proenkephalin, prodynorphin and proopiomelanocortin in the guinea pig pineal gland.

Authors:  H Schröder; E Weihe; D Nohr; L Vollrath
Journal:  Histochemistry       Date:  1988

3.  Regulation by delta-sleep-inducing peptide of the neurochemical changes in the brain associated with dopaminergic system hyperactivity.

Authors:  L M Gershtein; E L Dovedova
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

Review 4.  The effects of beta-endorphin: state change modification.

Authors:  Jan G Veening; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2015-01-29

5.  Mild exercise suppresses exacerbation of dermatitis by increasing cleavage of the β-endorphin from proopiomelanocortin in NC/Nga mice.

Authors:  Keiichi Hiramoto; Hiromi Kobayashi; Atsuo Sekiyama; Eisuke F Sato; Daisuke Tsuruta; Masamitsu Ishii
Journal:  J Clin Biochem Nutr       Date:  2012-11-20       Impact factor: 3.114

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.